Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1980 1
1997 1
1998 1
1999 1
2000 3
2001 1
2002 2
2003 7
2004 4
2005 5
2006 8
2007 6
2008 7
2009 5
2010 5
2011 8
2012 7
2013 14
2014 8
2015 9
2016 9
2017 5
2018 8
2019 4
2020 3
2021 2
2022 5
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 22991345

124 results

Results by year

Filters applied: . Clear all
Page 1
Psychostimulant effect of levodopa: reversing sensitisation is possible.
Castrioto A, Kistner A, Klinger H, Lhommée E, Schmitt E, Fraix V, Chabardès S, Mertens P, Quesada JL, Broussolle E, Pollak P, Thobois SC, Krack P. Castrioto A, et al. J Neurol Neurosurg Psychiatry. 2013 Jan;84(1):18-22. doi: 10.1136/jnnp-2012-302444. Epub 2012 Sep 18. J Neurol Neurosurg Psychiatry. 2013. PMID: 22991345 Clinical Trial.
Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.
Lhommée E, Klinger H, Thobois S, Schmitt E, Ardouin C, Bichon A, Kistner A, Fraix V, Xie J, Aya Kombo M, Chabardès S, Seigneuret E, Benabid AL, Mertens P, Polo G, Carnicella S, Quesada JL, Bosson JL, Broussolle E, Pollak P, Krack P. Lhommée E, et al. Brain. 2012 May;135(Pt 5):1463-77. doi: 10.1093/brain/aws078. Epub 2012 Apr 15. Brain. 2012. PMID: 22508959
Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.
Thobois S, Ardouin C, Lhommée E, Klinger H, Lagrange C, Xie J, Fraix V, Coelho Braga MC, Hassani R, Kistner A, Juphard A, Seigneuret E, Chabardes S, Mertens P, Polo G, Reilhac A, Costes N, LeBars D, Savasta M, Tremblay L, Quesada JL, Bosson JL, Benabid AL, Broussolle E, Pollak P, Krack P. Thobois S, et al. Brain. 2010 Apr;133(Pt 4):1111-27. doi: 10.1093/brain/awq032. Epub 2010 Mar 17. Brain. 2010. PMID: 20237128 Clinical Trial.
Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial.
Lhommée E, Wojtecki L, Czernecki V, Witt K, Maier F, Tonder L, Timmermann L, Hälbig TD, Pineau F, Durif F, Witjas T, Pinsker M, Mehdorn M, Sixel-Döring F, Kupsch A, Krüger R, Elben S, Chabardès S, Thobois S, Brefel-Courbon C, Ory-Magne F, Regis JM, Maltête D, Sauvaget A, Rau J, Schnitzler A, Schüpbach M, Schade-Brittinger C, Deuschl G, Houeto JL, Krack P; EARLYSTIM study group. Lhommée E, et al. Lancet Neurol. 2018 Mar;17(3):223-231. doi: 10.1016/S1474-4422(18)30035-8. Lancet Neurol. 2018. PMID: 29452685 Clinical Trial.
Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.
Delpont B, Lhommée E, Klinger H, Schmitt E, Bichon A, Fraix V, Castrioto A, Quesada JL, Pélissier P, Kistner A, Carnicella S, Lüscher C, Broussolle E, Pollak P, Thobois S, Krack P. Delpont B, et al. Mov Disord. 2017 Nov;32(11):1566-1573. doi: 10.1002/mds.27101. Epub 2017 Jul 24. Mov Disord. 2017. PMID: 28737225
124 results